What is Agilent Technologies's market cap?

Agilent Technologies (A) has a market capitalization of $37.09B as of June 15, 2026. Market cap is the total market value of the company's outstanding shares (share price × shares outstanding), shown here in US dollars (USD).

How is Agilent Technologies's market cap calculated, and what currency is it in?

Market capitalization is calculated by multiplying Agilent Technologies's share price by its total shares outstanding. Although Agilent Technologies reports its financial statements in USD, market cap on this page is shown in US dollars (USD) for comparability with other companies.

What is the highest market cap Agilent Technologies has reached?

Agilent Technologies (A) reached its all-time high market cap of $54.86B on September 3, 2021, based on daily closing values in our history.

What is the lowest market cap Agilent Technologies has reached?

Agilent Technologies (A) recorded its all-time low market cap of $3.13B on March 9, 2009 in the available daily history.

Is Agilent Technologies's market cap above or below its 5-year average?

At $37.09B, Agilent Technologies's market cap is currently below its five-year average of $39.46B.

What was Agilent Technologies's market cap in 2025?

Agilent Technologies (A) ended 2025 with a market cap of $41.57B.

What was Agilent Technologies's market cap in 2026?

Agilent Technologies (A) ended 2026 with a market cap of $37.09B.

Agilent Technologies (A) Market Cap History

Current

$37.09B

As of Jun 15, 2026

5-Year Average

$39.46B

All-Time High

$54.86B

Sep 3, 2021

All-Time Low

$3.13B

Mar 9, 2009

Market cap daily chart for Agilent Technologies (A)

Jun 16, 2021 – Jun 15, 2026 · 1,255 trading days

Market Cap growth chart for Agilent Technologies (A) from 2000 to 2026

Latest: -10.8%

Market Cap history table for Agilent Technologies (A) from 2000 to 2026


2026	$37.09B	-10.8%	−$4.48B	Jun 15, 2026	Jun 1, 2026
2025	$41.57B	+9.6%	+$3.65B	Oct 31, 2025	Dec 22, 2025
2024	$37.92B	+23.9%	+$7.32B	Oct 31, 2024	Dec 20, 2024
2023	$30.60B	-26.3%	−$10.91B	Oct 31, 2023	Dec 20, 2023
2022	$41.51B	-14.2%	−$6.84B	Oct 31, 2022	Dec 21, 2022
2021	$48.35B	+51.8%	+$16.50B	Oct 31, 2021	Dec 17, 2021
2020	$31.85B	+32.2%	+$7.76B	Oct 31, 2020	Dec 18, 2020
2019	$24.09B	+14.4%	+$3.03B	Oct 31, 2019	Dec 19, 2019
2018	$21.06B	-5.1%	−$1.12B	Oct 31, 2018	Dec 20, 2018
2017	$22.18B	+54.7%	+$7.84B	Oct 31, 2017	Dec 21, 2017
2016	$14.33B	+13.3%	+$1.68B	Oct 31, 2016	Dec 20, 2016
2015	$12.65B	-5.3%	−$711.54M	Oct 31, 2015	Dec 21, 2015
2014	$13.36B	+6.7%	+$837.64M	Oct 31, 2014	Dec 22, 2014
2013	$12.52B	+37.8%	+$3.44B	Oct 31, 2013	Dec 19, 2013
2012	$9.09B	-3.5%	−$324.83M	Oct 31, 2012	Dec 20, 2012
2011	$9.41B	+7.1%	+$624.88M	Oct 31, 2011	Dec 16, 2011
2010	$8.79B	+43.5%	+$2.67B	Oct 31, 2010	Dec 20, 2010
2009	$6.12B	+4.0%	+$232.97M	Oct 31, 2009	Dec 21, 2009
2008	$5.89B	-45.0%	−$4.81B	Oct 31, 2008	Dec 19, 2008
2007	$10.70B	+1.1%	+$118.51M	Oct 31, 2007	Dec 21, 2007
2006	$10.58B	-1.9%	−$205.41M	Oct 31, 2006	Dec 22, 2006
2005	$10.79B	+30.4%	+$2.51B	Oct 31, 2005	Jan 17, 2006
2004	$8.27B	+4.1%	+$329.53M	Oct 31, 2004	Dec 21, 2004
2003	$7.94B	+84.4%	+$3.64B	Oct 31, 2003	Dec 22, 2003
2002	$4.31B	-37.3%	−$2.56B	Oct 31, 2002	Dec 20, 2002
2001	$6.87B	-51.6%	−$7.33B	Oct 31, 2001	Jan 22, 2002
2000	$14.20B	—	—	Oct 31, 2000	Jan 17, 2001

2026$37.09B-10.8%
2025$41.57B+9.6%
2024$37.92B+23.9%
2023$30.60B-26.3%
2022$41.51B-14.2%
2021$48.35B+51.8%
2020$31.85B+32.2%
2019$24.09B+14.4%
2018$21.06B-5.1%
2017$22.18B+54.7%
2016$14.33B+13.3%
2015$12.65B-5.3%
2014$13.36B+6.7%
2013$12.52B+37.8%
2012$9.09B-3.5%
2011$9.41B+7.1%
2010$8.79B+43.5%
2009$6.12B+4.0%
2008$5.89B-45.0%
2007$10.70B+1.1%
2006$10.58B-1.9%
2005$10.79B+30.4%
2004$8.27B+4.1%
2003$7.94B+84.4%
2002$4.31B-37.3%
2001$6.87B-51.6%
2000$14.20B—

Market Cap values are taken from Agilent Technologies's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Market Cap at Agilent Technologies (A)

According to Agilent Technologies's latest reported financial statements, the company's latest reported market cap is $32.82B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).

Headline figure above is from the reporting period ending April 30, 2026 (reported June 1, 2026). Chart and table below cover the full reported history back to 2000.

2026's annual market cap for Agilent Technologies (A) came in at $37.09B – declined 10.8% year-over-year.

Looking at the 2021–2026 (5 years) stretch, Agilent Technologies market cap compounded at -5.2% per year, with a net decline across the window.

Agilent Technologies market cap peaked at $48.35B in 2021; the latest annual figure is $37.09B in 2026 (23.3% below peak).

$48.35B stands as the all-time-high annual market cap, posted in 2021, against a low of $4.31B during 2002.

Agilent Technologies Market Cap by Year

Agilent Technologies Market Cap 2026: $37.09B

2026's market cap for Agilent Technologies came in at $37.09B, declined 10.8% below 2025.

Agilent Technologies Market Cap 2025: $41.57B

Agilent Technologies posted market cap of $41.57B in 2025, grew 9.6% from 2024.

Agilent Technologies Market Cap 2024: $37.92B

In 2024, Agilent Technologies reported market cap of $37.92B, grew 23.9% from 2023.

Agilent Technologies Market Cap 2023: $30.60B

Agilent Technologies market cap in 2023 was $30.60B, declined 26.3% below 2022.

Agilent Technologies Market Cap 2022: $41.51B

Agilent Technologies market cap in 2022 was $41.51B.

See more financial history for Agilent Technologies (A).

Sector peers by Market Cap

Healthcare peers of Agilent Technologies (A), ranked by their latest market cap


Eli Lilly (LLY)	$1.06T
Johnson & Johnson (JNJ)	$567.28B
AbbVie (ABBV)	$391.50B
UnitedHealth Group (UNH)	$373.28B
Merck & Co. (MRK)	$283.78B
AstraZeneca (AZN)	$274.92B
Novo Nordisk (NVO)	$195.17B
Amgen (AMGN)	$189.18B

Frequently asked questions

Agilent Technologies (A) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation